← Evidence map

ReviewThe World Allergy Organization journal2025

Off-label applications of omalizumab: Current insights and perspectives.

Aleksandra Jaromin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41488545